Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06618794 · ClinicalTrials.gov registry record · NA

Recovery Legal Care Clinical Trial

A NA study of Firearm Injury and Economic Problems, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06618794: Recruiting NA study of Firearm Injury and Economic Problems, sponsored by University of Chicago.

NCT06618794 is a NA study of Firearm Injury and Economic Problems that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 500 participants, below the 5,425-participant average among 12 other Firearm Injury trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06618794, a NA study of Firearm Injury and Economic Problems, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

Hospital-Based Violence Intervention Programs (HVIPs) affiliated with trauma centers in the US often focus on individual behavior modification for reduction in re-victimization. There is a lack of reproducible evidence that has demonstrated effectiveness, given the exclusion of addressing inequities in the Social and Structural Determinants of Health (SSDOH), often the root causes of violent injury and preventable homicide. The study investigators created a Medical Legal Partnership (MLP) to partner with an existing HVIP. This novel program offers beside legal assistance to address the SSDOH. The purpose of this study is to evaluate the effectiveness of the HVIP-MLP program in improving violence-related outcomes, legal needs, health-related quality of life, PTSD symptoms, and perceived stress.

Primary Outcome

The Patient-Reported Outcomes Measurement Information System (PROMIS) scale measures self-reported psychological stress.

Interventions

  • OTHER Recovery Legal Care
  • OTHER HVIP Standard of Care

Study Locations (1)

Illinois

  • University of Chicago Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-02-10
Est. Completion 2027-08-31
Phase NA
University of Chicago

796 total trials

What NCT06618794 shows while recruiting

NCT06618794 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 5,425-participant average among 12 other Firearm Injury trials with a reported enrollment target (91% lower).

The record links to 4 conditions, with Firearm Injury appearing as the primary indexed condition, and to 2 interventions - of which Recovery Legal Care is the first listed.

NCT06618794 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06618794 about?

NCT06618794 is a clinical study titled "Recovery Legal Care Clinical Trial". Hospital-Based Violence Intervention Programs (HVIPs) affiliated with trauma centers in the US often focus on individual behavior modification for reduction in re-victimization. There is a lack of reproducible evidence that has demonstrated effectiveness, given the exclusion of addressing inequities...

What is the current status of trial NCT06618794?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-02-10. Estimated completion is 2027-08-31.

What conditions does trial NCT06618794 study?

This clinical trial studies the following conditions: Firearm Injury, Economic Problems, Racism, Systemic, Injury Traumatic.

What interventions are being tested in trial NCT06618794?

The interventions under investigation include: Recovery Legal Care (OTHER), HVIP Standard of Care (OTHER).

Who is sponsoring clinical trial NCT06618794?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06618794 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Firearm Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06618794's enrollment target sits among peer trials

500 4th of 12 higher than 9 of 12 other Firearm Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Firearm Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06618794, the US trial registry maintained by the National Library of Medicine. NCT06618794 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.